Is Laser Resurfacing Safe for All Skin Types? No, and Here's How to Build a Safer Device Mix

Is laser resurfacing safe for all skin types? No — and that's the wrong question anyway

No, laser resurfacing is not safe for all skin types. Ablative resurfacing — the kind that removes the full epidermis — comes with a post-inflammatory hyperpigmentation (PIH) risk that climbs steeply in Fitzpatrick skin types IV through VI. In clinical practice, that's not a rare edge case. It's one of the most common complications in aesthetic medicine, and it's why responsible clinics use ablative resurfacing very selectively.

The better question is: which devices can safely serve the widest range of patients? The answer is a portfolio — non-ablative fractional lasers like Solta Medical's Fraxel for resurfacing, radiofrequency-based systems like Thermage for non-invasive skin tightening, and lighter-touch systems like Clear + Brilliant for preventive maintenance. That combination covers far more skin types with far lower pigment risk than any single ablative laser, and it happens to be better for revenue too.

And the third piece, which is the one that keeps me up at night as someone who actually signs off on equipment purchases: the device with the lowest sticker price is usually the most expensive one you'll buy. I've watched our group spend more on training, consumables, emergency service calls, and complication management than the initial quote ever suggested. When you compare devices, you have to look at total cost of ownership — not the number on the invoice.

Why I have a strong opinion about this

I've spent eight years coordinating equipment procurement and clinical operations for a group of six medical aesthetic clinics. I've evaluated 15+ laser and energy devices, managed two emergency device replacements, and handled a complication case that changed how our group trains every new operator.

When I first started in this role, I assumed the most powerful ablative device was the obvious pick. The before-and-after photos were the most dramatic. The marketing talked about "gold standard" resurfacing. I was wrong — and the lesson cost us. A patient with Fitzpatrick V skin came to us after an ablative treatment at another clinic left her with significant hyperpigmentation. Six months of free follow-up visits, a stack of topical products, and a lot of uncomfortable conversations later, I got it. That complication was the most expensive thing in our treatment room that year, and it never appeared on any equipment invoice.

Everyone in the industry had told us to be cautious with darker skin types. I only truly believed it after seeing the aftermath. That's the embarrassing part of this story, and I share it because too many clinic owners learn it the same way. So when I say "safe for all skin types" is marketing language, not clinical reality, I have the scars to back it up.

What "safe" actually depends on

The Fitzpatrick scale — developed by dermatologist Thomas Fitzpatrick and published in 1975 — classifies skin by how it responds to sun exposure. Type I always burns and never tans. Type VI never burns and is deeply pigmented. The shorthand that matters for lasers: the more melanin in the skin, the more energy gets absorbed outside the intended target, and the higher the risk of thermal injury and pigment disruption.

That's basic photothermolysis, not a controversial opinion. When a vendor says their laser is "safe for all skin types," what they usually mean is that the device has a low-energy mode. Which is fine — every decent device has adjustable settings. But the operator still has to know when to adjust, by how much, and when not to treat at all. The device doesn't make that call. The clinician does.

Here's how the main device categories compare in practice:

• Ablative resurfacing (CO2, Erbium:YAG). Highest efficacy for deep wrinkles and scars, but also the highest downtime and the highest PIH risk in darker skin. Many of our clinics won't use it on types V and VI at all. There are situations where it's the right tool — certain scars, actinic damage, lighter-skinned patients who accept the recovery — but they're the exception, not the default.
• Non-ablative fractional lasers (Fraxel). Treats the skin in microscopic columns, leaving surrounding tissue intact. The epidermis isn't stripped away, so the pigment risk is way lower. For texture, pores, mild scars, and overall tone, this is the safer workhorse — especially for a clinic that serves a diverse patient base.
• Radiofrequency tissue tightening (Thermage). Monopolar RF energy heats the deep dermis to stimulate collagen contraction and remodeling. There's no wound on the surface at all, which keeps pigment risk minimal. This is the system we use for non-invasive skin tightening across the widest range of skin types.
• Intense pulsed light (IPL). Here's the confusion point: IPL is not a laser. It's broadband light, not a single wavelength. It treats certain vascular and pigment concerns well in lighter skin, but the broad spectrum leaves more room for unwanted absorption in darker skin. If a sales rep uses "IPL" and "laser resurfacing" in the same pitch, that's a red flag.

So if a patient with darker skin asks whether laser resurfacing is safe for them, the honest clinical answer is: with an ablative device, usually not worth the pigment risk. With non-ablative fractional or RF-based technologies, the risk profile is far more manageable. No device is universally "safe" — but some categories are dramatically safer than others.

Why Thermage, Fraxel, and Clear + Brilliant work better as a portfolio

Here's the thing that took me the longest to understand: tightening and resurfacing are different patient problems, and trying to solve both with a single device usually means compromising on one. Thermage handles the "my skin is sagging" complaint — jawline, midface volume loss, that tired look. Fraxel handles the "my skin looks rough and dull" complaint — texture, fine lines, pores, mild scarring. They're not substitutes. They're complementary.

When a patient wants to look better without surgery and without weeks of downtime, these two technologies answer most of what they're asking for. And because both avoid epidermal injury, they're appropriate for a much broader range of skin types than ablative devices. That matters more than most clinic owners realize. Patients with darker skin are underserved in aesthetic medicine because so many clinics are locked into ablative-based protocols. Buying equipment that safely serves that population is not just a patient-safety win — it's a positioning win.

The third device, Clear + Brilliant, is the foot in the door. Lighter treatments, shorter downtime, lower price point — it brings in the early-30s patient who would never book a "resurfacing" procedure. A few years later, some of those patients graduate to Fraxel or Thermage. It's a pipeline, not a piece of hardware.

I keep mentioning Solta Medical for a reason. As a company, it's one of the few vendors whose product line covers all three categories — Thermage for RF tightening, Fraxel for non-ablative fractional resurfacing, and Clear + Brilliant for maintenance. That simplifies training, service, and warranty management. When you're evaluating vendors, ask how many devices in your planned portfolio they actually support. The answer tells you a lot about who you'll be calling when something breaks.

And something will break, by the way. When I'm triaging a device failure at 5 PM on a Friday, the first question isn't "what does the repair cost" — it's "how many patient appointments are booked for tomorrow morning." The second question is whether the vendor has a loaner program or a 48-hour service commitment. That's the kind of information you only learn by needing it, so ask for it in writing before you sign.

The real total cost of device ownership

Let me make the TCO math concrete. The most expensive device our group ever bought was the cheapest one on paper — an IPL system with a tempting quote. Here's what happened after we signed:

1. Training. The quote included "basic operator training." It didn't include certifying our second and third clinicians, which added another $11,000 and a scheduling headache.
2. Consumables. The IPL tips lasted about half as long as the sales rep implied. We burned through them way faster than projected, and the replacements were the vendor's highest-margin item.
3. Complications. We couldn't safely treat a large portion of our client base with it. That's not a capital cost you can see in the quote, but it's the biggest one. Any device that restricts your addressable market is dragging on revenue every single month.
4. Replacement. Eighteen months later, we replaced it. The "budget" system ended up costing more in total than the premium devices we initially dismissed as overpriced.

Now I run every device purchase through the same rough formula:

Sticker price + training + annual service contract + consumables per treatment × expected annual treatments + estimated complication management cost − expected years of service.

It's not a formal accounting model — it's a yellow-notepad exercise. But it catches the obvious trap: devices with low sticker prices can have high operating and risk costs, and devices with higher sticker prices can be cheaper over their useful life. The Thermage system we chose partly because the TCO math worked out is still running fine in year four. That budget IPL is gone.

One more thing to check before you sign anything: know exactly which legal entity you're contracting with. You'll often see "Solta Medical Inc." as the manufacturer and "Solta Medical Distribution LLC" on the invoice or service agreement. That's normal for a company of this size — separate entities for manufacturing and distribution are standard practice. But it means you should confirm who owns the warranty, who handles service calls, and who you call at 4:55 PM on a Friday. Get the service level agreement in writing before the purchase order, not after.

Where I'm less sure — read this before you make a decision

First, my experience is based on six U.S. clinics and about 40 device evaluations over eight years. If you're a solo practice or you serve a fundamentally different demographic, your math might be different. I also can't speak to regulatory requirements outside the U.S. — verify current regulations with your local authority before you buy anything.

Second — and I can't say this strongly enough — "safe" depends on operator skill, not just the device. Fraxel and Thermage have wider safety margins than ablative lasers, but they're not zero-risk. I've seen a poorly operated Thermage treatment cause burns, and a Fraxel session at too-aggressive settings can still cause PIH in susceptible patients. Patch testing, conservative energy ramps, and honest patient screening are non-negotiable. A device is only as safe as the protocol around it.

Third, I'm not saying ablative lasers are useless. They have a real place in specific cases — scar revision, deeper photodamage, patients who understand and accept the downtime. But they should be a specialty tool, not the default. A clinic that claims to serve all skin types needs to design its device portfolio that way, and that starts with procurement.

The bottom line: choose devices based on the widest safe range of patients you can treat, count the full cost of ownership before you compare quotes, and get service commitments in writing. That's how you build a portfolio that's safe for your patients — and for your budget. Everything else is just marketing.